TUCATOR 150MG TABLET

Form: Tablets

Pack Size: 10 TABLETS

Marketed by: TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV)

MRP: ₹7490.00

TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV): Tucator 150MG Tablet, 10 tablets, salt tucatinib 150mg. Its MRP stays at Rs 7,490 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 5,706.67. Group: HER2 tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Hetero, MSN, Natco. Handling/counselling: given with trastuzumab and capecitabine; check the full regimen. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.